Skip to content

Blood test for screening of breast cancer using novel screening device, Pandora CDx MammoAlertTM

Multi-Centric Screening of Breast Cancer Patients to Determine Efficiency and to Assess Sensitivity & Accuracy of Pandora CDx MammoAlertTM in Screening of Breast Cancer.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/05/008716
Enrollment
2400
Registered
2017-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Breast Cancer Suspects

Interventions

Intervention1: Pandora CDx MammoAlert TM: POC Medical Systems has developed the Mammo Alert system using the Pandora CDx Platform which will allow for rapid low cost portable screening of millions of

Sponsors

POC Medical Systems Inc
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Sex female. b) Age between 18 and above. c) Ability to give informed consent. Written informed consent by the patient/patientâ??s legally acceptable representative (LAR) for donating blood sample. d) Documented absence of cancer, other than breast cancer

Exclusion criteria

Exclusion criteria: a) Other malignancy besides breast cancer in the 5 years prior to obtaining the sample. b) Therapies for breast cancer that have been administered in less than 1 year prior to obtaining the sample. c) Any condition (including psychiatric), which in the Investigatorâ??s opinion, places the patient at undue risk by participating in the study.

Design outcomes

Primary

MeasureTime frame
Efficiency of the Pandora CDx MammoAlertTM, a novel Breast Cancer Panel to screen subjects who are confirmed for breast cancer (Mix population of Stage I-IV of either IDC or ILC or both) by Mammography and/or Biopsy will be confirmedTimepoint: 6 months

Secondary

MeasureTime frame
The Sensitivity and Accuracy of Pandora CDx MammoAlertTM, a Breast Cancer Panel will be knownTimepoint: 6 months

Countries

India

Contacts

Public ContactDr Smita Singhania

Poc Medical Systems Inc

ssinghania@pocmedsys.com02226820389

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026